Skip to main content
Veterinary Medicines

PRILIUM 150 MG POWDER FOR ORAL SOLUTION FOR DOGS

Authorised
  • Imidapril hydrochloride

Product identification

Medicine name:
PRILIUM 150 MG POWDER FOR ORAL SOLUTION FOR DOGS
Prilium 150 mg Poeder voor drank
Prilium 150 mg Poudre pour solution buvable
Prilium 150 mg Pulver zur Herstellung einer Lösung zum Einnehmen
Active substance:
  • Imidapril hydrochloride
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Imidapril hydrochloride
    150.00
    milligram(s)
    /
    1.00
    Bottle
Pharmaceutical form:
  • Powder for oral solution
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QC09AA16
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Package description:
  • Box containing one 0.880 g powder vial and one 2 ml graduated syringe

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Vetoquinol
Marketing authorisation date:
Manufacturing sites for batch release:
  • VETOQUINOL
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V254204
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0133/002
Concerned member states:
  • Austria
  • Belgium
  • Czechia
  • Denmark
  • Finland
  • Germany
  • Greece
  • Hungary
  • Italy
  • Luxembourg
  • Poland
  • Portugal
  • Slovakia
  • United Kingdom (Northern Ireland)

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 22/03/2022
French (PDF)
Published on: 22/03/2022
German (PDF)
Published on: 22/03/2022

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 22/03/2022
French (PDF)
Published on: 22/03/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."